Literature DB >> 20082222

Correlation between breast density in mammography and background enhancement in MR mammography.

R Cubuk1, N Tasali, B Narin, F Keskiner, L Celik, S Guney.   

Abstract

PURPOSE: We aimed to analyse the influence of mammographic breast density on background enhancement (BE) at magnetic resonance (MR) mammography in pre- and postmenopausal women. In addition, we questioned predictability of contrast-enhancement dynamics of normal fibroglandular tissue (NFT) at MR mammography according to mammographic breast density.
MATERIALS AND METHODS: Twenty-six patients (mean age 51.54+/-11.5 years; range 37-79 years) who underwent both MR mammography and conventional mammography were included in this retrospective study. Fourteen patients were premenopausal and 12 were postmenopausal. The ethics committee of our institution approved the study. The mammograms were retrospectively reviewed for overall breast density according to the four-point scale (I-IV) of the Breast Imaging Reporting and Data System (BI-RADS) classification. Two radiologists, who were unaware of the clinical data, separately assessed the MR mammography images. Images were assessed for enhancement kinetic features (enhancement kinetic curve and the early-phase enhancement rate) and BE. MR mammography and conventional mammography findings were compared according to BI-RADS breast density category and menopausal status.
RESULTS: Percentage of increased signal intensity values during the first minute did not change according to mammographic breast density, and the mean early-phase enhancement rate scores were similar among breast density groups (p=0.942). There was no significant difference between pre- and postmenopausal groups. Enhancement kinetic features of the different groups based on BI-RADS breast density category and menopausal status were similar. There was no correlation between breast density and BE in either premenopausal (p=0.211) or in postmenopausal (p=0.735) groups.
CONCLUSIONS: We determined no correlation between mammographic breast density and so-called BE in MR mammography in either premenopausal or postmenopausal women. NFT at MR mammography cannot be predicted on the basis of mammographic breast density.

Entities:  

Mesh:

Year:  2010        PMID: 20082222     DOI: 10.1007/s11547-010-0513-4

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  30 in total

1.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

2.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.

Authors:  Francesco Sardanelli; Gian M Giuseppetti; Pietro Panizza; Massimo Bazzocchi; Alfonso Fausto; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

Review 3.  Diagnostic breast MR imaging: current status and future directions.

Authors:  Elizabeth A Morris
Journal:  Radiol Clin North Am       Date:  2007-09       Impact factor: 2.303

Review 4.  Mammographic parenchymal patterns and breast cancer risk.

Authors:  A F Saftlas; M Szklo
Journal:  Epidemiol Rev       Date:  1987       Impact factor: 6.222

Review 5.  Imaging breast cancer.

Authors:  Lia Bartella; Clare S Smith; D David Dershaw; Laura Liberman
Journal:  Radiol Clin North Am       Date:  2007-01       Impact factor: 2.303

6.  Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.

Authors:  P C Stomper; D J D'Souza; P A DiNitto; M A Arredondo
Journal:  AJR Am J Roentgenol       Date:  1996-11       Impact factor: 3.959

7.  Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer.

Authors:  M L Quan; L Sclafani; A S Heerdt; J V Fey; E A Morris; P I Borgen
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

8.  Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T.

Authors:  Andrea Teifke; Alexander Hlawatsch; Thomas Beier; Toni Werner Vomweg; Simin Schadmand; Markus Schmidt; Hans-Anton Lehr; Manfred Thelen
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

9.  Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.

Authors:  R D Rosenberg; W C Hunt; M R Williamson; F D Gilliland; P W Wiest; C A Kelsey; C R Key; M N Linver
Journal:  Radiology       Date:  1998-11       Impact factor: 11.105

Review 10.  Mammographic density. Measurement of mammographic density.

Authors:  Martin J Yaffe
Journal:  Breast Cancer Res       Date:  2008-06-19       Impact factor: 6.466

View more
  25 in total

1.  Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.

Authors:  Jeon-Hor Chen; Hon Yu; Muqing Lin; Rita S Mehta; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2013-08-29       Impact factor: 2.546

2.  Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?

Authors:  Takayoshi Uematsu; Masako Kasami; Junichiro Watanabe
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

Review 3.  Evaluation of background parenchymal enhancement on breast MRI: a systematic review.

Authors:  Bianca Bignotti; Alessio Signori; Francesca Valdora; Federica Rossi; Massimo Calabrese; Manuela Durando; Giovanna Mariscotto; Alberto Tagliafico
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

4.  Repeatability of quantitative MRI measurements in normal breast tissue.

Authors:  Sheye O Aliu; Ella F Jones; Ania Azziz; John Kornak; Lisa J Wilmes; David C Newitt; Sachiko A Suzuki; Catherine Klifa; Jessica Gibbs; Evelyn C Proctor; Bonnie N Joe; Nola M Hylton
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

5.  Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.

Authors:  Julie Sogani; Elizabeth A Morris; Jennifer B Kaplan; Donna D'Alessio; Debra Goldman; Chaya S Moskowitz; Maxine S Jochelson
Journal:  Radiology       Date:  2016-07-04       Impact factor: 11.105

6.  Multifocal, multicentric and contralateral breast cancers: breast MR imaging in the preoperative evaluation of patients with newly diagnosed breast cancer.

Authors:  V Girardi; G Carbognin; L Camera; I Baglio; A Bucci; F Bonetti; R Pozzi Mucelli
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

7.  Background Parenchymal Enhancement and Fibroglandular Tissue Proportion on Breast MRI: Correlation with Hormone Receptor Expression and Molecular Subtypes of Breast Cancer.

Authors:  Mesut Öztürk; Ahmet Veysel Polat; Yurdanur Süllü; Leman Tomak; Ayfer Kamalı Polat
Journal:  J Breast Health       Date:  2017-01-01

8.  The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer.

Authors:  Marissa Albert; Freya Schnabel; Jennifer Chun; Shira Schwartz; Jiyon Lee; Ana Paula Klautau Leite; Linda Moy
Journal:  Clin Imaging       Date:  2015-08-06       Impact factor: 1.605

9.  Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary study.

Authors:  Jeon-Hor Chen; Yeun-Chung Chang; Daniel Chang; Yi-Ting Wang; Ke Nie; Ruey-Feng Chang; Orhan Nalcioglu; Chiun-Sheng Huang; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2010-09-15       Impact factor: 2.546

10.  Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response.

Authors:  H Preibsch; L Wanner; S D Bahrs; B M Wietek; K C Siegmann-Luz; E Oberlecher; M Hahn; A Staebler; K Nikolaou; B Wiesinger
Journal:  Eur Radiol       Date:  2015-09-17       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.